Abstract:Amyloid precursor protein (APP) is a transmembrane protein expressed largely within the central nervous system. Upon cleavage, it does not produce the toxic amyloid peptide (Aβ) only, which is involved in neurodegenerative progressions but via a non-amyloidogenic pathway it is metabolized to produce a soluble fragment (sAPPα) through α-secretase. While a lot of studies are focusing on the role played by APP in the pathogenesis of Alzheimer's disease, sAPPα is reported to have numerous neuroprotective effects and it is being suggested as a candidate with possible therapeutic potential against Alzheimer's disease. However, the mechanisms through which sAPPα precisely works remain elusive. We have presented a comprehensive review of how sAPPα is regulating the neuroprotective effects in different biological models. Moreover, we have focused on the role of sAPPα during different developmental stages of the brain, neurogenic microenvironment in the brain and how this metabolite of APP is regulating the neurogenesis which is regarded as a compelling approach to ameliorate the impaired learning and memory deficits in dementia and diseases like Alzheimer's disease. sAPPα exerts beneficial physiological, biochemical and behavioral effects mitigating the detrimental effects of neurotoxic compounds. It has shown to increase the proliferation rate of numerous cell types and promised the synaptogenesis, neurite outgrowth, cell survival and cell adhesion. Taken together, we believe that further studies are warranted to investigate the exact mechanism of action so that sAPPα could be developed as a novel therapeutic target against neuronal deficits.

Functions of Amyloid Precursor Protein in Metabolic Diseases

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Physiological functions of APP family proteins.

The reciprocal relationship between amyloid precursor protein and mitochondrial function

The amyloid precursor protein: beyond amyloid

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Biology and Pathophysiology of the Amyloid Precursor Protein

Amyloid precursor protein and mitochondria

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

Role of APP in Neuronal Function

Secretases Related to Amyloid Precursor Protein Processing

APP Physiological and Pathophysiological Functions: Insights from Animal Models

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Amyloid Precursor Protein Revisited

The Role of APP in Alzheimer’s Disease

CELLULAR AND MOLECULAR BASIS OF Β-Amyloid PRECURSOR PROTEIN METABOLISM

Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα)

Advances in the β-amyloid precursor protein of Alzheimer's disease

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES